Nutricel Additive Solution – CP2D (Haemonetics Manufacturing Inc.)
Welcome to the PulseAid listing for the Nutricel Additive Solution – CP2D drug offered from Haemonetics Manufacturing Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Haemonetics Manufacturing Inc. |
| NON-PROPRIETARY NAME: | CP2D/AS-3 Anticoagulant and Additive System |
| SUBSTANCE NAME: | DEXTROSE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-09-13 |
| END MARKETING DATE: | 0000-00-00 |
Nutricel Additive Solution – CP2D HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nutricel Additive Solution – CP2D from Haemonetics Manufacturing Inc. |
| LABELER NAME: | Haemonetics Manufacturing Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.57(g/70mL) |
| START MARKETING DATE: | 2013-09-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 53157-100_25edc224-0331-45f2-842d-cc2b9514a9da |
| PRODUCT NDC: | 53157-100 |
| APPLICATION NUMBER: | BN820915 |
Other DEXTROSE Pharmaceutical Manufacturers / Labelers:
